期刊
JOURNAL OF INFECTIOUS DISEASES
卷 214, 期 -, 页码 S44-S50出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiw275
关键词
immune activation; inflammation; biomarkers; morbidity; mortality; HIV-1 infection; antiretroviral therapy
资金
- National Institutes of Health [R01AI110271, K23MH099916]
Despite marked improvements in the modern treatment era, human immunodeficiency virus (HIV)-infected individuals, particularly those who initiated antiretroviral therapy (ART) at advanced disease stages, continue to have increased age-related morbidity and mortality, compared with the general population. Immune activation and inflammation persist despite suppressive ART and predict many of these morbidities. The goal of this review is to examine the evidence suggesting a link between the persistent inflammatory state and morbidity and mortality in this setting, to describe the impact of early ART initiation on these factors, and to highlight important unanswered questions for the field. We also advance a hypothesis to explain why some morbidities-and their root inflammatory drivers-may be prevented more than others by early ART initiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据